Bin Shi
Impact in
- Cancer Research top 5%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
- Molecular Biology top 5%
- Epigenetics and DNA Methylation
- Cancer-related gene regulation
- Circular RNAs in diseases
- RNA modifications and cancer
- RNA Interference and Gene Delivery
- Ubiquitin and proteasome pathways
Papers in
-
- Angiogenesis and VEGF in Cancer 5
- RNA Research and Splicing 4
- RNA modifications and cancer 4
- Cancer-related gene regulation 4
- Epigenetics and DNA Methylation 4
-
- MicroRNA in disease regulation 7
- Cancer-related molecular mechanisms research 4
- Cancer, Hypoxia, and Metabolism 4
- Co-authors
- Laura Sepp‐Lorenzino (8 shared papers)Renato Baserga (5 shared papers)Tiziana DeAngelis (2 shared papers)Mien‐Chie Hung (3 shared papers)Marco di Prisco (2 shared papers)Marc Abrams (3 shared papers)Peter S. Linsley (1 shared paper)Chien‐Chen Lai (2 shared papers)
- Journals
- Journal of Cellular Physiology (3 papers)Journal of Histochemistry & Cytochemistry (3 papers)Nature Cell Biology (2 papers)Journal of Biological Chemistry (2 papers)Molecular Cancer Therapeutics (1 paper)
- Partner nations
- United StatesChinaTaiwan
In The Last Decade
Bin Shi
32 papers receiving 2.0k citations
Peers
Comparison fields: 5 of 106
- Cancer Research 623
- Molecular Biology 1.6k
- Oncology 329
- Genetics 249
- Biotechnology 50
Countries citing papers authored by Bin Shi
This map shows the geographic impact of Bin Shi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bin Shi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bin Shi more than expected).
Fields of papers citing papers by Bin Shi
This network shows the impact of papers produced by Bin Shi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bin Shi. The network helps show where Bin Shi may publish in the future.
Co-authors
The 25 scholars most cited alongside Bin Shi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 33 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2010 | 310 | |
| 2 | 2007 | 294 | |
| 3 | 2005 | 222 | |
| 4 | 2011 | 195 | |
| 5 | 2009 | 156 | |
| 6 | 2009 | 104 | |
| 7 | 1999 | 93 | |
| 8 | 2013 | 91 | |
| 9 | 2011 | 89 | |
| 10 | 2004 | 87 | |
| 11 | 2006 | 71 | |
| 12 | 2014 | 43 | |
| 13 | 2001 | 38 | |
| 14 | 2004 | 36 | |
| 15 | 2019 | 25 | |
| 16 | 2005 | 24 | |
| 17 | 2017 | 23 | |
| 18 | 2013 | 21 | |
| 19 | 2019 | 20 | |
| 20 | 2010 | 17 |
About Bin Shi
Bin Shi is a scholar working on Molecular Biology, Cancer Research, Oncology, Genetics and Pathology and Forensic Medicine, having authored 33 papers that have together received 2.0k indexed citations. Recurring topics across this work include MicroRNA in disease regulation (7 papers), Angiogenesis and VEGF in Cancer (5 papers), RNA Research and Splicing (4 papers), RNA modifications and cancer (4 papers), Cancer-related gene regulation (4 papers), Epigenetics and DNA Methylation (4 papers), Cancer-related molecular mechanisms research (4 papers) and Cancer, Hypoxia, and Metabolism (4 papers). The work is most often cited by research in Cancer Research (623 citations), Molecular Biology (1.6k citations), Oncology (329 citations), Genetics (249 citations) and Biotechnology (50 citations). Bin Shi has collaborated with scholars based in United States, China and Taiwan. Frequent co-authors include Laura Sepp‐Lorenzino, Renato Baserga, Tiziana DeAngelis, Mien‐Chie Hung, Marco di Prisco, Marc Abrams, Peter S. Linsley, Chien‐Chen Lai, Long‐Yuan Li and Chun-Yi Lin. Their work appears in journals such as Journal of Cellular Physiology, Journal of Histochemistry & Cytochemistry, Nature Cell Biology, Journal of Biological Chemistry and Molecular Cancer Therapeutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.